发明名称 Antifungal agents and uses thereof
摘要 The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
申请公布号 US9217014(B2) 申请公布日期 2015.12.22
申请号 US201414242192 申请日期 2014.04.01
申请人 Cidara Therapeutics, Inc. 发明人 James, Jr. Kenneth Duke;Laudeman Christopher Patrick;Malkar Navdeep Balkrishna;Radhakrishnan Balasingam
分类号 A61K38/00;A61K38/08;C07K7/00;C07K7/50;C07K7/06;C07K7/54;C07K7/56;C07K7/60;C07K7/64;A61K38/04 主分类号 A61K38/00
代理机构 Clark & Elbing LLP 代理人 Clark & Elbing LLP
主权项 1. A compound described by formula (la):wherein, R1 is O(CH2CH2O)nCH2CH2X1, O(CH2CH2CH2O)nCH2CH2X1, NHCH2CH2X2, NH(CH2CH2O)mCH2CH2X2, NH(CH2CH2CH2O)mCH2CH2X2, NH(CH2CH2O)pCH2CH2X3, NH(CH2CH2CH2O)pCH2CH2X3, NH[CH2(CH2)aO]bCH{CH2[OCH2(CH2)c]dX5}2, O[CH2(CH2)aO]bCH{CH2[OCH2(CH2)c]dX5}2, NH(CH2CH2NH)rCH2CH2X5, NHCH2(CH2)qX6, or OCH2(CH2)qX6; RT is n-pentyl, sec-pentyl, or iso-pentyl; X1 is NH2, NHRA1, NRA1RA2, or NRA1RA2RA3; X2 is OH or ORB1; X3 is NH2, NHRC1, NRC1RC2, or NRC1RC2RC3; each X5 is, independently, selected from OH, ORE1, NH2, NHRE1, NRE1RE2, or NRE1RE2RE3; X6 is selected from NRF1RF2RF3; a is an integer from 1 to 2; b is an integer from 0 to 3; c is an integer from 1 to 2; d is an integer from 0 to 3; n is an integer from 1 to 5; m is an integer from 1 to 5; p is an integer from 1 to 5; r is an integer from 1 to 5; q is an integer from 1 to 3; and each of RA1, RA2, RA3, RB1, RC1, RC2,RC3RE1, RE2, RE3, RF1, RF2, and RF3 is, independently, selected from CH3, CH2CH3, CH2CH2CH3, or CH(CH3)2, or a pharmaceutically acceptable salt thereof, wherein the compound is not compound 1 or a pharmaceutically acceptable salt thereof.
地址 San Diego CA US